Buy Laurus Labs: target of Rs 800: Sharekhan
Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated September 28, 2021.29-09-2021
29-09-2021
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings17-09-2021
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
The Company is pleased to announce that development is underway based on an agreement launched in June 2021 between the Company, Unitaid and the Clinton Health Access Initiative (CHAI), to accelerate the development, commercialization, and registration of the best-in-class second- and third-line HIV treatment darunavir boosted with ritonavir (DRV/r) for children. Despite being available in high-income countries for over a 15-year period, a generic, fixed-dose combination pediatric version of DRV/r is still not available. Through this agreement, Unitaid and CHAI are working with the Company to finally address this critical need and ensure CLHIV (Children Living with HIV/AIDS) have access to high-quality second- and third-line HIV treatment.14-09-2021
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings13-09-2021
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Axis Capital 2021 Rising Stars Conference on August 26-27, 202125-08-2021
Laurus Labs hits record high; rallies 17% in 7 days post Q1 results
The management holds a positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio -- and believes the outlook remains robust driven by improving demand and supported by capex09-08-2021
Three stock ideas by Osho Krishan of Anand Rathi: Buy Laurus Labs, Equitas
The stock of Laurus Labs is primarily in an uptrend and maintains the cycle of higher highs higher lows on all time frames06-08-2021
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
1QFY22 Earnings Conference Call Transcript03-08-2021
Buy Laurus Labs: target of Rs 800: Sharekhan
Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 800 in its research report dated July 30, 2021.02-08-2021
Laurus Labs rebounds 9% from day's low after 3 straight sessions of decline
The management maintains positive outlook across all four businesses -- FDF, APIs, Synthesis and Bio-- on the back of improving demand, and supported by capacity expansion plans planned30-07-2021